HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Cardiology2837 papers

Infective endocarditis

Last edited: 28 days ago

Overview

Infective endocarditis (IE) is a serious infection of the endocardium, typically involving the heart valves, characterized by the formation of vegetations that can lead to systemic embolization, heart failure, and significant morbidity and mortality. It predominantly affects individuals with preexisting valvular abnormalities, those with certain medical devices (e.g., prosthetic valves, catheters), and patients with underlying conditions such as rheumatic heart disease, intravenous drug use, and immunocompromised states. Early and accurate diagnosis is crucial for effective management and improved outcomes. Understanding the nuances of IE is essential in day-to-day practice to prevent complications and optimize patient care 1 2 3 15 22 32.

Pathophysiology

Infective endocarditis arises when microorganisms, often bacteria or fungi, enter the bloodstream and adhere to damaged or abnormal endocardial surfaces, typically heart valves. These adherent microorganisms form vegetations composed of fibrin, platelets, and inflammatory cells, which can break off, leading to embolic events affecting various organs. The immune response to these vegetations contributes to valvular dysfunction and can result in annular abscesses, perforation, and even heart failure. Molecularly, the interaction between microbial surface proteins and host endothelial receptors initiates a cascade of inflammatory and thrombotic events, amplifying the destructive process 1 5 22.

Epidemiology

The incidence of infective endocarditis varies globally but is estimated to range from 5 to 10 cases per 100,000 person-years. It predominantly affects older adults, with a median age around 60 years, though it can occur at any age, particularly in high-risk groups such as intravenous drug users and patients with prosthetic heart valves. Geographic variations exist, with higher rates reported in regions with higher prevalence of rheumatic heart disease. Risk factors include underlying valvular disease, immunosuppression, and certain medical interventions like hemodialysis and transcatheter procedures. Trends show an increasing incidence associated with injection drug use and the use of medical devices 3 6 18 24 30 36.

Clinical Presentation

Patients with infective endocarditis often present with nonspecific symptoms such as fever, fatigue, weight loss, and malaise. Classic signs include new or changing heart murmurs, petechiae, splinter hemorrhages, and signs of systemic embolization (e.g., stroke, abscesses). Atypical presentations can mimic other conditions, such as respiratory symptoms due to pulmonary embolism or gastrointestinal symptoms from embolic events. Red-flag features include persistent fever unresponsive to antibiotics, unexplained weight loss, and signs of heart failure or sepsis, necessitating urgent diagnostic evaluation 3 15 22 32.

Diagnosis

The diagnosis of infective endocarditis relies on clinical criteria combined with laboratory and imaging findings. The Modified Duke Criteria remain the gold standard, encompassing major and minor clinical, laboratory, and echocardiographic criteria. Key diagnostic steps include:

Clinical Criteria:

- Major Criteria: - Positive blood culture(s) with organism consistent with IE - Evidence of endocardial involvement by echocardiography (vegetation, abscess, valve ring abscess) - New regurgitant murmur in a previously normal valve - Minor Criteria: - Fever - Vascular phenomena (e.g., petechiae, splinter hemorrhages, retinal hemorrhages) - Immunological phenomena (e.g., anemia, elevated ESR, CRP) - Positive echocardiogram with inconclusive findings - Positive blood culture that is not clinically explained

Laboratory Tests:

- Blood cultures (repeated if necessary) - Complete blood count (CBC) with differential - Elevated inflammatory markers (ESR, CRP) - Echocardiography (transthoracic and transesophageal when indicated)

Echocardiographic Findings:

- Vegetation size ≥1 cm is often considered significant - Presence of perivalvular abscess or valve dysfunction

Differential Diagnosis:

- Acute Coronary Syndrome: Elevated troponin levels, ECG changes, absence of vegetation on echo - Pericarditis: Pericardial friction rub, absence of vegetations, characteristic ECG changes - Septic Arthritis: Localized joint swelling, warmth, and tenderness without systemic emboli - Device-Related Infections: Specific imaging findings related to the device site 2 5 15 22 32 35.

Management

Initial Management

Antibiotic Therapy:

- First-Line: - Bacteria: Empiric broad-spectrum antibiotics tailored based on blood cultures (e.g., vancomycin + gentamicin for Staphylococcus aureus, ampicillin + ceftriaxone for enterococci) - Duration: Typically 4-6 weeks, adjusted based on response and culture sensitivity - Monitoring: Regular blood cultures, renal function, and hearing assessments (for aminoglycosides)

Supportive Care:

- Fluid management, hemodynamic support - Management of heart failure symptoms - Treatment of embolic events (e.g., anticoagulation, surgical intervention)

Second-Line and Refractory Cases

Refractory Infections:

- Second-Line Antibiotics: Consider alternative agents based on resistance patterns (e.g., linezolid for MRSA, daptomycin for gram-positive pathogens) - Combination Therapy: For severe or resistant cases, consult infectious disease specialists for tailored regimens

Surgical Intervention:

- Indications: - Failure of medical therapy - Large vegetations (≥10 mm) - Perivalvular abscess - Severe valvular dysfunction - Persistent sepsis despite antibiotics - Procedures: Valve repair or replacement, abscess drainage, removal of infected devices

Contraindications

Severe Renal Impairment: Adjust dosing of nephrotoxic antibiotics (e.g., aminoglycosides)

Known Allergies: Avoid specific antibiotic classes based on patient history

Complications

Acute Complications:

- Embolic Events: Stroke, peripheral emboli, mycotic aneurysms - Heart Failure: Due to valvular dysfunction or annular abscesses - Septic Shock: Systemic inflammatory response leading to hemodynamic instability

Long-Term Complications:

- Chronic Heart Failure: Persistent valvular damage - Recurrent IE: Increased risk in certain patient populations - Mechanical Valve Dysfunction: Thrombosis, structural failure

Management Triggers:

- Persistent fever, recurrent emboli, worsening valvular function - Refer to cardiothoracic surgery for surgical intervention when indicated 1 5 15 22 32 35.

Prognosis & Follow-up

The prognosis of infective endocarditis varies widely, with mortality rates ranging from 10% to 30%, particularly in left-sided infections. Prognostic indicators include the presence of embolic events, underlying valvular disease, and the causative organism (e.g., Staphylococcus aureus has a worse prognosis). Follow-up typically involves:

Short-Term:

- Regular clinical assessments - Serial echocardiograms to monitor vegetations and valve function - Blood cultures to ensure clearance of infection

Long-Term:

- Cardiac function monitoring (echocardiography, ECG) - Periodic imaging to assess for late complications (e.g., aneurysm formation) - Regular follow-up with cardiology and infectious disease specialists 1 5 15 22 32.

Special Populations

Pediatrics

Presentation: Often presents with nonspecific symptoms; careful history and physical examination crucial

Management: Tailored antibiotic therapy based on age-specific dosing and renal function

Elderly

Considerations: Increased comorbidities, potential drug interactions, and altered pharmacokinetics

Monitoring: Frequent clinical and laboratory monitoring due to higher risk of complications

Injection Drug Users

Prevention: Emphasis on harm reduction strategies

Management: Early surgical intervention may be necessary due to higher risk of refractory infections 1 18 22 32.

Key Recommendations

Use Modified Duke Criteria for Diagnosis: Ensure comprehensive evaluation including clinical, laboratory, and echocardiographic findings (Evidence: Strong) 2

Empiric Broad-Spectrum Antibiotics: Initiate based on suspected pathogens until culture results are available (Evidence: Strong) 1 5

Echocardiography: Perform transthoracic echocardiography initially, with transesophageal echocardiography if inconclusive (Evidence: Moderate) 5 15

Antibiotic Duration: Maintain a standard course of 4-6 weeks, adjusted based on clinical response and culture sensitivity (Evidence: Moderate) 1 15

Surgical Intervention for Refractory Cases: Consider early surgical consultation for large vegetations, persistent sepsis, or valvular dysfunction (Evidence: Moderate) 1 5 22

Supportive Care: Manage heart failure symptoms and embolic events aggressively (Evidence: Moderate) 15

Follow-Up Monitoring: Regular echocardiograms and clinical assessments post-treatment to monitor for recurrence and complications (Evidence: Moderate) 1 22

Risk Factor Management: Address underlying conditions (e.g., valve repair, device removal) to reduce recurrence risk (Evidence: Moderate) 1 15

Specialized Care for High-Risk Groups: Tailor management for pediatric, elderly, and injection drug users considering specific vulnerabilities (Evidence: Expert opinion) 1 18 22

Prevention Strategies: Implement guidelines for dental and invasive procedures to reduce IE risk, especially in high-risk populations (Evidence: Moderate) 25

References

Showing 100 most recent of 1666 indexed papers.

1 Anton CI, Ranetti RC, Streinu-Cercel A. The Biological Cost of Every Heartbeat: Imaging-Derived Cardiovascular Vulnerability in Infective Endocarditis. International journal of molecular sciences 2026. link 2 Caldonazo T, Tasoudis P, Doenst T, Moris D, Kang L, Moschovas A et al.. Overall Accuracy of the Modified Duke Criteria-A Systematic Review and Meta-analysis. The Thoracic and cardiovascular surgeon 2026. link 3 Zhang Y, Yi L. A 62-Year-Old Man With Tricuspid Valve Endocarditis, Bacteremia, and Septic Pulmonary Embolism Following Long-Needle Acupuncture. The American journal of case reports 2026. link 4 Luque Paz D, Cañas MA, Cuervo G, Espasa M, Hernandez-Meneses M, Quintana E et al.. In vitro activity of amoxicillin combined with oral cephalosporins against endocarditis-associated E. faecalis clinical isolates. The Journal of antimicrobial chemotherapy 2026. link 5 San Román JA, Sevilla T, Cabezón G, López J, de Miguel M, Oña A et al.. Assessing And Managing Embolic Risk in Left-Sided Infective Endocarditis. The Canadian journal of cardiology 2026. link 6 Pérez-García CN, Olmos C, García-Arribas D, Jerónimo A, Gómez-Ramírez D, Sáez C et al.. Frailty predicts in-hospital and 1-year outcomes in patients with infective endocarditis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2026. link 7 Ali Hassan SM, Patel SK, Zarathus-Cook M, Lee G, Majeed H, Fagan A et al.. Percutaneous Mechanical Aspiration: A Game Changer for Infective Endocarditis?. The Canadian journal of cardiology 2026. link 8 Janson JT, Fourie B, Goussard P, Rabie H, Kim J. Mitral Valve Leaflet Repair with Autologous Saphenous Vein in a Child with Infective Endocarditis. Pediatric cardiology 2026. link 9 Jang DH, Kim DH, Choi ES, Kwon BS, Park CS, Yun TJ. Risk Factors for Infective Endocarditis in Contegra Grafts Used as Right Ventricle-Pulmonary Artery Conduits: A Retrospective Cohort Study. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2026. link 10 Agrawal A, Arockiam AD, Dahdah JE, Honnekeri B, Schleicher M, Shekhar S et al.. Comparisons of Risk Scores for Infective Endocarditis Surgery: A Meta-Analysis. Angiology 2026. link 11 Bartsch P, Krebs O, Augustin C, Aepfelbacher M, Rohde H, Berinson B. IS-Pro-based pathogen detection in explanted heart valves of suspected endocarditis patients. Microbiology spectrum 2026. link 12 Amaya MJ, Monroy AMDP, Perez N, Villamizar PD, Cardenas JP, Pinto Pinzón DA. Infective endocarditis of a prosthetic mechanical valve caused by Trichosporon inkin in an immunocompetent patient: Case report. Revista iberoamericana de micologia 2026. link 13 Iglesias-Varea J, Kirkegaard-Biosca C, Pizzi MN, Rello P, Rodríguez Lecoq R, Roque A et al.. Infective Endocarditis After Transcatheter Aortic Valve Implantation: Current Challenges in Diagnosis, Management, and Prevention. The Canadian journal of cardiology 2026. link 14 Marin-Cuartas M, Dietze Z, Freiburger S, Weber C, Luehr M, De La Cuesta M et al.. Early extraction versus conservative management in patients with noninfected cardiac implantable electronic devices undergoing cardiac surgery for left-sided infective endocarditis: Insights from the multicentric Clinical Multicenter Project for Analysis of Infective Endocarditis in Germany Registry. The Journal of thoracic and cardiovascular surgery 2026. link 15 Hindy JR, Chesdachai S, DeSimone DC, Anavekar NS, Stevens RW, Arghami A et al.. Medical Management in Adult Patients Following Cardiac Valve Surgery for Infective Endocarditis: A Comprehensive Review. The Canadian journal of cardiology 2026. link 16 Oprea A, Dădârlat-Pop A, Manea A, Gavanescu C, Toma G, Mot S et al.. Management challenges of tongue piercing-associated mitral valve endocarditis with systemic embolization in a 16-year-old patient. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2026. link 17 Theofilis P, Dimitriadis K, Pyrpyris N, Karakasis P, Dri E, Beneki E et al.. Invasive versus conservative management in infective endocarditis after transcatheter aortic valve implantation: A systematic review and meta-analysis. Current problems in cardiology 2026. link 18 Krymko H, Abelson N, El Mahdi N, Hain G, Ria M, Grunseid M et al.. Predictors of definite and possible infective endocarditis in children with bacteremia: a reginal cohort study. European journal of pediatrics 2026. link 19 Leis BT, Cote M, Connors WJ, Davierwala PM, Brothers TD, Morton LM et al.. Management of Infective Endocarditis Secondary to Injection Drug Use: Practical Recommendations for Clinicians From a Canadian Working Group. The Canadian journal of cardiology 2026. link 20 Delaunay M, Creveuil C, Dargère S, Isnard C, Saloux E, Fournier A et al.. Assessing the risk of infective endocarditis in Staphylococcus aureus bacteremia: a comparison of 4 scoring systems. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2026. link 21 Hernández-Meneses B, Sandoval E, Peña A, Gil-Sala D, Barquero M, Yugueros X et al.. Assessing Risk of Bloodstream Infections in Patients With Cardiovascular Devices: From Endocarditis to Cardiovascular Infections Team. The Canadian journal of cardiology 2026. link 22 Roque A, Wiefels C, Lau L, Cuellar-Calabria H, Palomar Muñoz A, Diez MJ et al.. Contemporary Approaches to the Use of Imaging in Infective Endocarditis. The Canadian journal of cardiology 2026. link 23 Lefevre B, Habib G, Hoen B, Selton-Suty C, Philip M, Issa N et al.. (no title). Infectious diseases (London, England) 2026. link 24 Kamisaka K, Okamoto H, Nishi T, Sasahira Y, Kanaoka K, Sumita Y et al.. Clinical Characteristics and Outcomes of Infective Endocarditis in Patients Undergoing Maintenance Hemodialysis　- A Retrospective Nationwide Database Analysis. Circulation journal : official journal of the Japanese Circulation Society 2026. link 25 Thornhill MH, Dayer MJ, Prendergast BD, Baddour LM. Endocarditis Prophylaxis-Indications, Application and Current Controversies. The Canadian journal of cardiology 2026. link 26 Henriques D, Guedes S, Antunes J, Anjos R. Pasteurella canis Endocarditis in a Healthy Child: A Rare Diagnosis With Unknown Origin. The Pediatric infectious disease journal 2026. link 27 Engelbrecht A, Doubell AF, Pecoraro AJK. Challenges of Infective Endocarditis in South Africa, a Low- to Middle-Income Country. The Canadian journal of cardiology 2026. link 28 Tran LNB, Zhuo R, Singha M, Sekhon H, Yang S, Fishbein GA et al.. First reported case of Capnocytophaga cynodegmi infective endocarditis: A diagnostic odyssey. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2026. link 29 Armange L, Blanc Petitjean P, Le Bot A, Luque Paz D, Lecomte R, Jaffuel S et al.. Preoperative coronary evaluation in valve surgery for infective endocarditis: findings from a multicenter retrospective study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2026. link 30 Consuegra Pérez MÁ, Grillo S, Rombauts A, Rivera Martínez MA, Falcó-Roget A, Albasanz-Puig A et al.. Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study. International journal of antimicrobial agents 2026. link 31 Yiming A, Ma X, Chen X, Chen Z, Yang S, Zhao J et al.. Diagnosis and classification of infective endocarditis via efficient serum metabolic fingerprint analysis. Biosensors & bioelectronics 2026. link 32 Greek A, Patel SK, Hassan SMA, Saleh Y, Goveas C, Yanagawa B. Sex differences in postoperative outcomes for infective endocarditis. Current opinion in cardiology 2026. link 33 Kobayashi S, Numata R, Machino-Ohtsuka T, Suzuki H, Ishizu T. Successful Management of Infective Endocarditis Utilizing Rapid High-performance Liquid Chromatography-based Therapeutic Drug Monitoring: Balancing Linezolid Efficacy and Thrombocytopenia Risk. Internal medicine (Tokyo, Japan) 2026. link 34 Zheng K, Hao Y, Guo C, Ye W, Luo Z, Li X et al.. Development and validation of a dynamic prediction model for infective endocarditis patients based on platelet trajectories latent classes: a longitudinal retrospective study from multicenter databases. International journal of surgery (London, England) 2026. link 35 Emara A, Emara M, Aldemerdash MA, Hemmeda L, Gadelmawla AF, Saber A et al.. Impact of aortic root abscess on outcomes in infective endocarditis and predictors of in-hospital mortality: A meta-analysis. Heart & lung : the journal of critical care 2026. link 36 Watson SA, Mbonye KA, Deharo F, Freidin MB, Fairhurst N, Letteri N et al.. The influence of social deprivation in infective endocarditis: a retrospective observational study of the London endocarditis research network. European heart journal. Quality of care & clinical outcomes 2026. link 37 Zeb R, Sharma S, Abdullah R, Patel M, Nallamotu S, Veintemilla-Burgos F et al.. Sex does not influence outcomes in valvular heart surgery due to infective endocarditis: A systematic review and meta-analysis. Asian cardiovascular & thoracic annals 2026. link 38 Zwischenberger BA, Odei A, Jensen C, Colton K, Carr K, Gaca JG et al.. Relative Importance of Timing vs Size of Preoperative Stroke for Valve Operation in Infective Endocarditis. The Annals of thoracic surgery 2026. link 39 Wang W, Chen F, Ye L, Chen O, Qing H, Zhuang L et al.. Enhanced diagnostic yield and clinical impact of metagenomic next-generation sequencing in infective endocarditis: a continuous and prospective surgical cohort study. International journal of surgery (London, England) 2026. link 40 Lee JS, Sales VL, Moter A, Eichinger W. Early Surgical Outcomes in Infective Endocarditis Before and During COVID-19 Pandemic. The Thoracic and cardiovascular surgeon 2026. link 41 Zimmermann V, Fourré N, Ledergerber B, Epprecht J, Siedentop B, Monney P et al.. Risk of endocarditis in patients with bacteraemia by coagulase-negative staphylococci; a multicenter retrospective cohort. European journal of internal medicine 2026. link 42 Lau L, Xing L, Baddour LM, Chan V, Messika-Zeitoun D. The Evolving Landscape of Infective Endocarditis: Past, Present, and Future. The Canadian journal of cardiology 2026. link 43 Gotor-Rivera A, Alejo Fernández-Baillo JL, Acosta-Hernández J, Carpy MDP, Infanta MDR, López-Medrano F. Antithrombotic agents: Do they protect from infective endocarditis? A retrospective observational study using TriNetx. Enfermedades infecciosas y microbiologia clinica (English ed.) 2026. link 44 Rewthamrongsris P, Thongchotchat V, Burapacheep J, Trachoo V, Khurshid Z, Porntaveetus T. Evaluating Retrieval-Augmented Generation-Large Language Models for Infective Endocarditis Prophylaxis: Clinical Accuracy and Efficiency. International dental journal 2026. link 45 Rallet B, Pouy R, Coutureau C, Blot M, Bani-Sadr F, Sixt T et al.. Should We Extend the Use of Oral Antibiotics in Infective Endocarditis? The ENDO-ORAL Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026. link 46 Kurland S, Furebring M, Löwdin E, Olaison L, Sjölin J. Antifungal Therapy in Candida Infective Endocarditis: A Comparison of Echinocandins and Other Treatment Regimens in a Nationwide Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026. link 47 Martinsson A, Thorleifsson S, David A, Rawshani A, Snygg-Martin U, Redfors B et al.. Infective Endocarditis After Arrythmia Device Implantation in Cardiac Surgery Patients. Journal of the American Heart Association 2026. link 48 Park JH, Chen E, Joseph DE, Wanger A, Viehman JA, Padival S. Prevalence and Risk Factors for Non-HACEK Gram-negative Bacillus Endocarditis: A Retrospective Analysis. The Canadian journal of cardiology 2026. link 49 Khayata M, Goff Z, Gordon S, Callahan T, Elgharably H, Unai S et al.. Role of multimodality imaging in cardiac implantable electronic devices related infection and infective endocarditis. Expert review of medical devices 2026. link 50 Grillo S, Isler B, Bonet-Basiero A, Roselló-Díez E, Escolà-Vergé L. Does Biological Sex Determine the Natural History and Management of Infective Endocarditis?. The Canadian journal of cardiology 2026. link 51 Roberts KEA, Okumu EA, McInnes B, Ostrach B, Chu VH, Wu LT et al.. "It Eats My Heart": Identifying Knowledge Gaps in Injection Drug-Related Endocarditis Among Hospitalized Patients. Substance use & addiction journal 2026. link 52 Regina J, Ianculescu N, Tzimas G, Monney P, Niclauss L, Kirsch M et al.. Rethinking the Routine: Are Repeat Blood Cultures Necessary After Completion of Infective Endocarditis Treatment?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2026. link 53 Che S, Li J, Lu J, Wu D, Xie Q, Yang J et al.. Predictive value of troponin T for short-term outcomes in patients with infective endocarditis. Archives of cardiovascular diseases 2026. link 54 Matesva M, Furlani AC, Haramati LB, Bader AS. Showers Head to Toe: Imaging of Infective Endocarditis. Journal of computer assisted tomography 2026. link 55 Papadimitriou-Olivgeris M, Monney P, Frank M, Tzimas G, Fourre N, Zimmermann V et al.. Comparison of the 2015 and 2023 Duke-European Society of Cardiology Criteria Among Patients With Suspected Infective Endocarditis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025. link 56 Caldonazo T, Doenst T, Fazzini L, Kirov H, Hagel S, Lehmann T et al.. Sex differences on the effect of hemoadsorption during cardiac surgery - A REMOVE trial post-hoc analysis. International journal of cardiology 2025. link 57 Leanza GM, Rando E, Frondizi F, Taddei E, Giovannenze F, Horcajada JP et al.. A systematic review of dalbavancin efficacy as a sequential therapy for infective endocarditis. Infection 2025. link 58 Dörfler J, Grubitzsch H, Schneider-Reigbert M, Pasic M, Pfäfflin F, Stegemann M et al.. Non-HACEK gram-negative bacilli infective endocarditis: data from a retrospective German cohort study. Infection 2025. link 59 Held ME, Stambough JB, McConnell ZA, Mears SC, Barnes CL, Stronach BM. Simultaneous Periprosthetic Joint Infection and Infective Endocarditis: Prevalence, Risk Factors, and Clinical Presentation. The Journal of arthroplasty 2025. link 60 Palom-Grau C, Cuervo G, Muñoz P, Marín Arriaza M, Martínez-Sellés M, González-Ramallo V et al.. A Contemporary Picture of Coagulase-Negative Staphylococcal Endocarditis: A Nationwide GAMES Cohort Study. Journal of the American College of Cardiology 2025. link 61 Takasu S, Matsumoto S, Kanto Y, Iwadate K. Ruptured Aortic Valve Aneurysm Caused by Infective Endocarditis in a SARS-CoV-2-Positive Autopsy Case. The American journal of forensic medicine and pathology 2025. link 62 Daniel E, El-Nayir M, Ezeani C, Nwaezeapu K, Ogedegbe OJ, Khan M. The role of multimodal imaging in the diagnosis of prosthetic valve and intracardiac device endocarditis: A review. The international journal of cardiovascular imaging 2025. link 63 Todt K. Caring for Patients With Injection Drug Use-Associated Infective Endocarditis at the End of Life: A Modified Photo-Elicitation Phenomenological Study. Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association 2025. link 64 Chan CA, Minahan-Rowley R, Biegacki ET, Sue KL, Weimer MB. Development of a Patient and Clinician Informed Website on Injection Drug Use Related Infective Endocarditis. Substance use & addiction journal 2025. link 65 Schubert L, Chen RY, Weiss-Tessbach M, Kriz R, Obermüller M, Jackwerth M et al.. 25 years of experience on the management of enterococcal infective endocarditis an observational study. Infection 2025. link 66 Boukobza M, Rebibo L, Ilic-Habensus E, Iung B, Duval X, Laissy JP. Splenic abscess and infective endocarditis. Infection 2025. link 67 Sordelli C, Verde R, Fele N, Weisz SH, Severino L, Perrella A et al.. A case of a huge aortic pseudo-aneurysm following aortic bioprosthetic endocarditis: the key role of 3D echocardiography. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2025. link 68 Liu W, Li Y, Yang H, Wang J, Lan W, Li C et al.. Cardiac surgery timing on the prognosis of patients with infective endocarditis. Journal of cardiothoracic surgery 2025. link 69 Brugiatelli L, Patani F, Lofiego C, Benedetti M, Capodaglio I, Giulia P et al.. Multimodality Imaging in Infective Endocarditis: A Clinical Approach to Diagnosis. Medicina (Kaunas, Lithuania) 2025. link 70 Bertolino L, Unar A, Patauner F, Gallo R, Peluso AMC, Delle Femine A et al.. Embolic complications in a large contemporary cohort of infective endocarditis: do we need score model?. Infection 2025. link 71 Okamoto H, Nishi T, Kamisaka K, Sasahira Y, Kanaoka K, Sumita Y et al.. Trends in the Clinical Characteristics and Outcome of Infective Endocarditis: A Nationwide Study From 2016 to 2021. Journal of the American Heart Association 2025. link 72 Hasegawa S, Takahashi H, Yamanaka K, Okada K. New strategy of early surgery for infective endocarditis complicated by intracranial hemorrhage. Surgery today 2025. link 73 Khayata M, Grimm RA, Griffin BP, Xu B. Prevalence, Characteristics, and Outcomes of Infective Endocarditis Readmissions in Patients With Variables Associated With Liver Disease in the United States. Angiology 2025. link 74 Avogadri N, Ivarsson A, Burup Kristensen C, Ragnarsson S, Rasmussen M. Evaluation of the 2023 Duke-ISCVID criteria for infective endocarditis in patients referred to the Lund infective endocarditis team. Infectious diseases (London, England) 2025. link 75 Latifian M, Mostafavi E, Broumand MA, Bagheri Amiri F, Mohammadi MR, Esmaeili S. Molecular investigation of Coxiella burnetii and Bartonella in heart valve specimens of patients with endocarditis in Iran. Journal of infection and public health 2025. link 76 Patel SK, Hassan SMA, Côté M, Leis B, Yanagawa B. Current trends and challenges in infective endocarditis. Current opinion in cardiology 2025. link 77 González-Arjona M, Sobrino G, Cussó L, Guembe M, Calle D, Díaz Crespo F et al.. (no title). ACS infectious diseases 2025. link 78 Mendez-Hirata G, Rivera-Buendía F, Viveros-Rentería E, Ochoa-Hein E, Cornejo-Juárez P, Márquez M et al.. Clinical Characteristics and Outcomes of Infective Endocarditis in Patients with Cancer: A Multicenter Case-Control Study. Archives of medical research 2025. link 79 Rewthamrongsris P, Burapacheep J, Trachoo V, Porntaveetus T. Accuracy of Large Language Models for Infective Endocarditis Prophylaxis in Dental Procedures. International dental journal 2025. link 80 Takahashi Y, Nakade J, Zaimoku Y, Watanabe N, Watari T, Otsuka Y et al.. Culture-negative infective endocarditis due to Neisseria bacilliformis identified via 16S rRNA gene analysis from resected valve tissue: Case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2025. link 81 Robson C, Horvath R, Stuart RL, Nicholls SJ, Smith JA, Rogers BA. A national study of infective endocarditis models of care in Australia. Internal medicine journal 2025. link 82 Siddharth B, Dammalapati PK, V V, Said S. Novel Use of the Right Atrial Appendage as a Neopulmonary Valve in a Child With Infective Endocarditis. World journal for pediatric & congenital heart surgery 2025. link 83 Bobrovski VG, Prestes MO, Pinheiro AL, Zacarkim E, Kist A, Dos Santos Reis ES. Hospital mortality due to infective endocarditis: Analysis of risk factors in a developing country. Current problems in cardiology 2025. link 84 Aparicio-Minguijón E, Boán J, Terrón A, Heredia C, Puente C, Pérez-Jacoiste Asín A et al.. Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients. Enfermedades infecciosas y microbiologia clinica (English ed.) 2025. link 85 Sato T, Osawa T, Ochi A, Fumikura Y, Machino-Ohtsuka T, Yamasaki H et al.. Cardiac Device-related Infective Endocarditis and Retrosternal Abscess Treated with Percutaneous Lead Extraction and Antimicrobials. Internal medicine (Tokyo, Japan) 2025. link 86 Callegari A, Albertini M, Reverdito G, Bonnet D, Malekzadeh-Milani S. Interventional Treatment of Acute Right Ventricular Outflow Tract Infectious Endocarditis: A Bridge to Surgical or Percutaneous Pulmonary Valve Replacement. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2025. link 87 Ai S, Liu X, Zhao N, Miao Q, Qin Y, Li X. Risk factors of infective endocarditis-associated acute kidney injury: benefits of low-dose amikacin and surgery. Annals of medicine 2025. link 88 Lee TTL, Ju C, Chan SCL, Chou OHI, Chan JSK, Lee S et al.. Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation. Journal of the American Heart Association 2025. link 89 Yuan Y, Ma L, Liang Y, Zhao S, Shi Q, Yu Z et al.. Fatal Rhodococcus erythropolis endocarditis complicated by an abscess invading the atrioventricular node: a case report. Forensic science, medicine, and pathology 2025. link 90 Alabi AO, Sayomi BA, Oladibu OT, Adetoye MM, Aderinto N, Akintunde AA. Isolated pulmonary valve endocarditis in a 7-year-old Nigerian girl: a case report. Journal of medical case reports 2025. link 91 Kim T, Song K, Oh H, Song JY, Lee K, Sun BJ et al.. Clinical and Imaging Characteristics of Infective Endocarditis-Associated Versus Atrial Fibrillation-Associated Stroke. Journal of the American Heart Association 2025. link 92 Yu L, Lv T, Yang Y. A case of infective endocarditis with the manifestation of multi-organ embolisms: a case report. Cardiovascular journal of Africa 2025. link 93 Sperotto F, France K, Gobbo M, Bindakhil M, Pimolbutr K, Holmes H et al.. Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures: A Systematic Review and Meta-Analysis. JAMA cardiology 2024. link 94 Imazio M. The 2023 new European guidelines on infective endocarditis: main novelties and implications for clinical practice. Journal of cardiovascular medicine (Hagerstown, Md.) 2024. link 95 Moisset H, Rio J, Suc G, Benhard J, Arnoult F, Deconinck L et al.. Evaluation of the specificity of the 2023 European Society of Cardiology classification for infective endocarditis. Infectious diseases (London, England) 2024. link 96 Oldberg K, Rasmussen M. Make Modern Microbiology Matter More in the 2023 European Society of Cardiology Guidelines for the Management of Infective Endocarditis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024. link 97 Papadimitriou-Olivgeris M, Monney P, Frank M, Tzimas G, Tozzi P, Kirsch M et al.. Evaluation of the 2023 Duke-ISCVID and 2023 Duke-ESC Clinical Criteria for the Diagnosis of Infective Endocarditis in a Multicenter Cohort of Patients With Staphylococcus aureus Bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024. link 98 Sunnerhagen T, Rasmussen M. Lower Specificity of the European Society of Cardiology 2023 Diagnostic Criteria for Infective Endocarditis When Spondylodiscitis Is Regarded as a Vascular Phenomenon. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024. link 99 Goehringer F, Lalloué B, Selton-Suty C, Alla F, Botelho-Nevers E, Chirouze C et al.. Compared Performance of the 2023 Duke-International Society for Cardiovascular Infectious Diseases, 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the Diagnosis of Infective Endocarditis in a French Multicenter Prospective Cohort. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024. link 100 Umemoto D, Hara S, Nishioka H. Infective endocarditis and septic arthritis caused by Corynebacteriumstriatum. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2024. link

Original source

[1]
The Biological Cost of Every Heartbeat: Imaging-Derived Cardiovascular Vulnerability in Infective Endocarditis. — Anton CI, Ranetti RC, Streinu-Cercel A International journal of molecular sciences (2026)
[2]
Overall Accuracy of the Modified Duke Criteria-A Systematic Review and Meta-analysis. — Caldonazo T, Tasoudis P, Doenst T, Moris D, Kang L, Moschovas A et al. The Thoracic and cardiovascular surgeon (2026)
[3]
A 62-Year-Old Man With Tricuspid Valve Endocarditis, Bacteremia, and Septic Pulmonary Embolism Following Long-Needle Acupuncture. — Zhang Y, Yi L The American journal of case reports (2026)
[4]
In vitro activity of amoxicillin combined with oral cephalosporins against endocarditis-associated E. faecalis clinical isolates. — Luque Paz D, Cañas MA, Cuervo G, Espasa M, Hernandez-Meneses M, Quintana E et al. The Journal of antimicrobial chemotherapy (2026)
[5]
Assessing And Managing Embolic Risk in Left-Sided Infective Endocarditis. — San Román JA, Sevilla T, Cabezón G, López J, de Miguel M, Oña A et al. The Canadian journal of cardiology (2026)
[6]
Frailty predicts in-hospital and 1-year outcomes in patients with infective endocarditis. — Pérez-García CN, Olmos C, García-Arribas D, Jerónimo A, Gómez-Ramírez D, Sáez C et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2026)
[7]
Percutaneous Mechanical Aspiration: A Game Changer for Infective Endocarditis? — Ali Hassan SM, Patel SK, Zarathus-Cook M, Lee G, Majeed H, Fagan A et al. The Canadian journal of cardiology (2026)
[8]
Mitral Valve Leaflet Repair with Autologous Saphenous Vein in a Child with Infective Endocarditis. — Janson JT, Fourie B, Goussard P, Rabie H, Kim J Pediatric cardiology (2026)
[9]
Risk Factors for Infective Endocarditis in Contegra Grafts Used as Right Ventricle-Pulmonary Artery Conduits: A Retrospective Cohort Study. — Jang DH, Kim DH, Choi ES, Kwon BS, Park CS, Yun TJ European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2026)
[10]
Comparisons of Risk Scores for Infective Endocarditis Surgery: A Meta-Analysis. — Agrawal A, Arockiam AD, Dahdah JE, Honnekeri B, Schleicher M, Shekhar S et al. Angiology (2026)
[11]
IS-Pro-based pathogen detection in explanted heart valves of suspected endocarditis patients. — Bartsch P, Krebs O, Augustin C, Aepfelbacher M, Rohde H, Berinson B Microbiology spectrum (2026)
[12]
Infective endocarditis of a prosthetic mechanical valve caused by Trichosporon inkin in an immunocompetent patient: Case report. — Amaya MJ, Monroy AMDP, Perez N, Villamizar PD, Cardenas JP, Pinto Pinzón DA Revista iberoamericana de micologia (2026)
[13]
Infective Endocarditis After Transcatheter Aortic Valve Implantation: Current Challenges in Diagnosis, Management, and Prevention. — Iglesias-Varea J, Kirkegaard-Biosca C, Pizzi MN, Rello P, Rodríguez Lecoq R, Roque A et al. The Canadian journal of cardiology (2026)
[14]
Early extraction versus conservative management in patients with noninfected cardiac implantable electronic devices undergoing cardiac surgery for left-sided infective endocarditis: Insights from the multicentric Clinical Multicenter Project for Analysis of Infective Endocarditis in Germany Registry. — Marin-Cuartas M, Dietze Z, Freiburger S, Weber C, Luehr M, De La Cuesta M et al. The Journal of thoracic and cardiovascular surgery (2026)
[15]
Medical Management in Adult Patients Following Cardiac Valve Surgery for Infective Endocarditis: A Comprehensive Review. — Hindy JR, Chesdachai S, DeSimone DC, Anavekar NS, Stevens RW, Arghami A et al. The Canadian journal of cardiology (2026)
[16]
Management challenges of tongue piercing-associated mitral valve endocarditis with systemic embolization in a 16-year-old patient. — Oprea A, Dădârlat-Pop A, Manea A, Gavanescu C, Toma G, Mot S et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2026)
[17]
Invasive versus conservative management in infective endocarditis after transcatheter aortic valve implantation: A systematic review and meta-analysis. — Theofilis P, Dimitriadis K, Pyrpyris N, Karakasis P, Dri E, Beneki E et al. Current problems in cardiology (2026)
[18]
Predictors of definite and possible infective endocarditis in children with bacteremia: a reginal cohort study. — Krymko H, Abelson N, El Mahdi N, Hain G, Ria M, Grunseid M et al. European journal of pediatrics (2026)
[19]
Management of Infective Endocarditis Secondary to Injection Drug Use: Practical Recommendations for Clinicians From a Canadian Working Group. — Leis BT, Cote M, Connors WJ, Davierwala PM, Brothers TD, Morton LM et al. The Canadian journal of cardiology (2026)
[20]
Assessing the risk of infective endocarditis in Staphylococcus aureus bacteremia: a comparison of 4 scoring systems. — Delaunay M, Creveuil C, Dargère S, Isnard C, Saloux E, Fournier A et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2026)
[21]
Assessing Risk of Bloodstream Infections in Patients With Cardiovascular Devices: From Endocarditis to Cardiovascular Infections Team. — Hernández-Meneses B, Sandoval E, Peña A, Gil-Sala D, Barquero M, Yugueros X et al. The Canadian journal of cardiology (2026)
[22]
Contemporary Approaches to the Use of Imaging in Infective Endocarditis. — Roque A, Wiefels C, Lau L, Cuellar-Calabria H, Palomar Muñoz A, Diez MJ et al. The Canadian journal of cardiology (2026)
[23]
(no title) — Lefevre B, Habib G, Hoen B, Selton-Suty C, Philip M, Issa N et al. Infectious diseases (London, England) (2026)
[24]
Clinical Characteristics and Outcomes of Infective Endocarditis in Patients Undergoing Maintenance Hemodialysis　- A Retrospective Nationwide Database Analysis. — Kamisaka K, Okamoto H, Nishi T, Sasahira Y, Kanaoka K, Sumita Y et al. Circulation journal : official journal of the Japanese Circulation Society (2026)
[25]
Endocarditis Prophylaxis-Indications, Application and Current Controversies. — Thornhill MH, Dayer MJ, Prendergast BD, Baddour LM The Canadian journal of cardiology (2026)
[26]
Pasteurella canis Endocarditis in a Healthy Child: A Rare Diagnosis With Unknown Origin. — Henriques D, Guedes S, Antunes J, Anjos R The Pediatric infectious disease journal (2026)
[27]
Challenges of Infective Endocarditis in South Africa, a Low- to Middle-Income Country. — Engelbrecht A, Doubell AF, Pecoraro AJK The Canadian journal of cardiology (2026)
[28]
First reported case of Capnocytophaga cynodegmi infective endocarditis: A diagnostic odyssey. — Tran LNB, Zhuo R, Singha M, Sekhon H, Yang S, Fishbein GA et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2026)
[29]
Preoperative coronary evaluation in valve surgery for infective endocarditis: findings from a multicenter retrospective study. — Armange L, Blanc Petitjean P, Le Bot A, Luque Paz D, Lecomte R, Jaffuel S et al. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2026)
[30]
Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study. — Consuegra Pérez MÁ, Grillo S, Rombauts A, Rivera Martínez MA, Falcó-Roget A, Albasanz-Puig A et al. International journal of antimicrobial agents (2026)
[31]
Diagnosis and classification of infective endocarditis via efficient serum metabolic fingerprint analysis. — Yiming A, Ma X, Chen X, Chen Z, Yang S, Zhao J et al. Biosensors & bioelectronics (2026)
[32]
Sex differences in postoperative outcomes for infective endocarditis. — Greek A, Patel SK, Hassan SMA, Saleh Y, Goveas C, Yanagawa B Current opinion in cardiology (2026)
[33]
Successful Management of Infective Endocarditis Utilizing Rapid High-performance Liquid Chromatography-based Therapeutic Drug Monitoring: Balancing Linezolid Efficacy and Thrombocytopenia Risk. — Kobayashi S, Numata R, Machino-Ohtsuka T, Suzuki H, Ishizu T Internal medicine (Tokyo, Japan) (2026)
[34]
Development and validation of a dynamic prediction model for infective endocarditis patients based on platelet trajectories latent classes: a longitudinal retrospective study from multicenter databases. — Zheng K, Hao Y, Guo C, Ye W, Luo Z, Li X et al. International journal of surgery (London, England) (2026)
[35]
Impact of aortic root abscess on outcomes in infective endocarditis and predictors of in-hospital mortality: A meta-analysis. — Emara A, Emara M, Aldemerdash MA, Hemmeda L, Gadelmawla AF, Saber A et al. Heart & lung : the journal of critical care (2026)
[36]
The influence of social deprivation in infective endocarditis: a retrospective observational study of the London endocarditis research network. — Watson SA, Mbonye KA, Deharo F, Freidin MB, Fairhurst N, Letteri N et al. European heart journal. Quality of care & clinical outcomes (2026)
[37]
Sex does not influence outcomes in valvular heart surgery due to infective endocarditis: A systematic review and meta-analysis. — Zeb R, Sharma S, Abdullah R, Patel M, Nallamotu S, Veintemilla-Burgos F et al. Asian cardiovascular & thoracic annals (2026)
[38]
Relative Importance of Timing vs Size of Preoperative Stroke for Valve Operation in Infective Endocarditis. — Zwischenberger BA, Odei A, Jensen C, Colton K, Carr K, Gaca JG et al. The Annals of thoracic surgery (2026)
[39]
Enhanced diagnostic yield and clinical impact of metagenomic next-generation sequencing in infective endocarditis: a continuous and prospective surgical cohort study. — Wang W, Chen F, Ye L, Chen O, Qing H, Zhuang L et al. International journal of surgery (London, England) (2026)
[40]
Early Surgical Outcomes in Infective Endocarditis Before and During COVID-19 Pandemic. — Lee JS, Sales VL, Moter A, Eichinger W The Thoracic and cardiovascular surgeon (2026)
[41]
Risk of endocarditis in patients with bacteraemia by coagulase-negative staphylococci; a multicenter retrospective cohort. — Zimmermann V, Fourré N, Ledergerber B, Epprecht J, Siedentop B, Monney P et al. European journal of internal medicine (2026)
[42]
The Evolving Landscape of Infective Endocarditis: Past, Present, and Future. — Lau L, Xing L, Baddour LM, Chan V, Messika-Zeitoun D The Canadian journal of cardiology (2026)
[43]
Antithrombotic agents: Do they protect from infective endocarditis? A retrospective observational study using TriNetx. — Gotor-Rivera A, Alejo Fernández-Baillo JL, Acosta-Hernández J, Carpy MDP, Infanta MDR, López-Medrano F Enfermedades infecciosas y microbiologia clinica (English ed.) (2026)
[44]
Evaluating Retrieval-Augmented Generation-Large Language Models for Infective Endocarditis Prophylaxis: Clinical Accuracy and Efficiency. — Rewthamrongsris P, Thongchotchat V, Burapacheep J, Trachoo V, Khurshid Z, Porntaveetus T International dental journal (2026)
[45]
Should We Extend the Use of Oral Antibiotics in Infective Endocarditis? The ENDO-ORAL Study. — Rallet B, Pouy R, Coutureau C, Blot M, Bani-Sadr F, Sixt T et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2026)
[46]
Antifungal Therapy in Candida Infective Endocarditis: A Comparison of Echinocandins and Other Treatment Regimens in a Nationwide Cohort Study. — Kurland S, Furebring M, Löwdin E, Olaison L, Sjölin J Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2026)
[47]
Infective Endocarditis After Arrythmia Device Implantation in Cardiac Surgery Patients. — Martinsson A, Thorleifsson S, David A, Rawshani A, Snygg-Martin U, Redfors B et al. Journal of the American Heart Association (2026)
[48]
Prevalence and Risk Factors for Non-HACEK Gram-negative Bacillus Endocarditis: A Retrospective Analysis. — Park JH, Chen E, Joseph DE, Wanger A, Viehman JA, Padival S The Canadian journal of cardiology (2026)
[49]
Role of multimodality imaging in cardiac implantable electronic devices related infection and infective endocarditis. — Khayata M, Goff Z, Gordon S, Callahan T, Elgharably H, Unai S et al. Expert review of medical devices (2026)
[50]
Does Biological Sex Determine the Natural History and Management of Infective Endocarditis? — Grillo S, Isler B, Bonet-Basiero A, Roselló-Díez E, Escolà-Vergé L The Canadian journal of cardiology (2026)
[51]
"It Eats My Heart": Identifying Knowledge Gaps in Injection Drug-Related Endocarditis Among Hospitalized Patients. — Roberts KEA, Okumu EA, McInnes B, Ostrach B, Chu VH, Wu LT et al. Substance use & addiction journal (2026)
[52]
Rethinking the Routine: Are Repeat Blood Cultures Necessary After Completion of Infective Endocarditis Treatment? — Regina J, Ianculescu N, Tzimas G, Monney P, Niclauss L, Kirsch M et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2026)
[53]
Predictive value of troponin T for short-term outcomes in patients with infective endocarditis. — Che S, Li J, Lu J, Wu D, Xie Q, Yang J et al. Archives of cardiovascular diseases (2026)
[54]
Showers Head to Toe: Imaging of Infective Endocarditis. — Matesva M, Furlani AC, Haramati LB, Bader AS Journal of computer assisted tomography (2026)
[55]
Comparison of the 2015 and 2023 Duke-European Society of Cardiology Criteria Among Patients With Suspected Infective Endocarditis. — Papadimitriou-Olivgeris M, Monney P, Frank M, Tzimas G, Fourre N, Zimmermann V et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2025)
[56]
Sex differences on the effect of hemoadsorption during cardiac surgery - A REMOVE trial post-hoc analysis. — Caldonazo T, Doenst T, Fazzini L, Kirov H, Hagel S, Lehmann T et al. International journal of cardiology (2025)
[57]
A systematic review of dalbavancin efficacy as a sequential therapy for infective endocarditis. — Leanza GM, Rando E, Frondizi F, Taddei E, Giovannenze F, Horcajada JP et al. Infection (2025)
[58]
Non-HACEK gram-negative bacilli infective endocarditis: data from a retrospective German cohort study. — Dörfler J, Grubitzsch H, Schneider-Reigbert M, Pasic M, Pfäfflin F, Stegemann M et al. Infection (2025)
[59]
Simultaneous Periprosthetic Joint Infection and Infective Endocarditis: Prevalence, Risk Factors, and Clinical Presentation. — Held ME, Stambough JB, McConnell ZA, Mears SC, Barnes CL, Stronach BM The Journal of arthroplasty (2025)
[60]
A Contemporary Picture of Coagulase-Negative Staphylococcal Endocarditis: A Nationwide GAMES Cohort Study. — Palom-Grau C, Cuervo G, Muñoz P, Marín Arriaza M, Martínez-Sellés M, González-Ramallo V et al. Journal of the American College of Cardiology (2025)
[61]
Ruptured Aortic Valve Aneurysm Caused by Infective Endocarditis in a SARS-CoV-2-Positive Autopsy Case. — Takasu S, Matsumoto S, Kanto Y, Iwadate K The American journal of forensic medicine and pathology (2025)
[62]
The role of multimodal imaging in the diagnosis of prosthetic valve and intracardiac device endocarditis: A review. — Daniel E, El-Nayir M, Ezeani C, Nwaezeapu K, Ogedegbe OJ, Khan M The international journal of cardiovascular imaging (2025)
[63]
Caring for Patients With Injection Drug Use-Associated Infective Endocarditis at the End of Life: A Modified Photo-Elicitation Phenomenological Study. — Todt K Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association (2025)
[64]
Development of a Patient and Clinician Informed Website on Injection Drug Use Related Infective Endocarditis. — Chan CA, Minahan-Rowley R, Biegacki ET, Sue KL, Weimer MB Substance use & addiction journal (2025)
[65]
25 years of experience on the management of enterococcal infective endocarditis an observational study. — Schubert L, Chen RY, Weiss-Tessbach M, Kriz R, Obermüller M, Jackwerth M et al. Infection (2025)
[66]
Splenic abscess and infective endocarditis. — Boukobza M, Rebibo L, Ilic-Habensus E, Iung B, Duval X, Laissy JP Infection (2025)
[67]
A case of a huge aortic pseudo-aneurysm following aortic bioprosthetic endocarditis: the key role of 3D echocardiography. — Sordelli C, Verde R, Fele N, Weisz SH, Severino L, Perrella A et al. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace (2025)
[68]
Cardiac surgery timing on the prognosis of patients with infective endocarditis. — Liu W, Li Y, Yang H, Wang J, Lan W, Li C et al. Journal of cardiothoracic surgery (2025)
[69]
Multimodality Imaging in Infective Endocarditis: A Clinical Approach to Diagnosis. — Brugiatelli L, Patani F, Lofiego C, Benedetti M, Capodaglio I, Giulia P et al. Medicina (Kaunas, Lithuania) (2025)
[70]
Embolic complications in a large contemporary cohort of infective endocarditis: do we need score model? — Bertolino L, Unar A, Patauner F, Gallo R, Peluso AMC, Delle Femine A et al. Infection (2025)
[71]
Trends in the Clinical Characteristics and Outcome of Infective Endocarditis: A Nationwide Study From 2016 to 2021. — Okamoto H, Nishi T, Kamisaka K, Sasahira Y, Kanaoka K, Sumita Y et al. Journal of the American Heart Association (2025)
[72]
New strategy of early surgery for infective endocarditis complicated by intracranial hemorrhage. — Hasegawa S, Takahashi H, Yamanaka K, Okada K Surgery today (2025)
[73]
Prevalence, Characteristics, and Outcomes of Infective Endocarditis Readmissions in Patients With Variables Associated With Liver Disease in the United States. — Khayata M, Grimm RA, Griffin BP, Xu B Angiology (2025)
[74]
Evaluation of the 2023 Duke-ISCVID criteria for infective endocarditis in patients referred to the Lund infective endocarditis team. — Avogadri N, Ivarsson A, Burup Kristensen C, Ragnarsson S, Rasmussen M Infectious diseases (London, England) (2025)
[75]
Molecular investigation of Coxiella burnetii and Bartonella in heart valve specimens of patients with endocarditis in Iran. — Latifian M, Mostafavi E, Broumand MA, Bagheri Amiri F, Mohammadi MR, Esmaeili S Journal of infection and public health (2025)
[76]
Current trends and challenges in infective endocarditis. — Patel SK, Hassan SMA, Côté M, Leis B, Yanagawa B Current opinion in cardiology (2025)
[77]
(no title) — González-Arjona M, Sobrino G, Cussó L, Guembe M, Calle D, Díaz Crespo F et al. ACS infectious diseases (2025)
[78]
Clinical Characteristics and Outcomes of Infective Endocarditis in Patients with Cancer: A Multicenter Case-Control Study. — Mendez-Hirata G, Rivera-Buendía F, Viveros-Rentería E, Ochoa-Hein E, Cornejo-Juárez P, Márquez M et al. Archives of medical research (2025)
[79]
Accuracy of Large Language Models for Infective Endocarditis Prophylaxis in Dental Procedures. — Rewthamrongsris P, Burapacheep J, Trachoo V, Porntaveetus T International dental journal (2025)
[80]
Culture-negative infective endocarditis due to Neisseria bacilliformis identified via 16S rRNA gene analysis from resected valve tissue: Case report and review of the literature. — Takahashi Y, Nakade J, Zaimoku Y, Watanabe N, Watari T, Otsuka Y et al. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (2025)
[81]
A national study of infective endocarditis models of care in Australia. — Robson C, Horvath R, Stuart RL, Nicholls SJ, Smith JA, Rogers BA Internal medicine journal (2025)
[82]
Novel Use of the Right Atrial Appendage as a Neopulmonary Valve in a Child With Infective Endocarditis. — Siddharth B, Dammalapati PK, V V, Said S World journal for pediatric & congenital heart surgery (2025)
[83]
Hospital mortality due to infective endocarditis: Analysis of risk factors in a developing country. — Bobrovski VG, Prestes MO, Pinheiro AL, Zacarkim E, Kist A, Dos Santos Reis ES Current problems in cardiology (2025)
[84]
Dalbavancin as sequential therapy in infective endocarditis: Real-life experience in elder and comorbid patients. — Aparicio-Minguijón E, Boán J, Terrón A, Heredia C, Puente C, Pérez-Jacoiste Asín A et al. Enfermedades infecciosas y microbiologia clinica (English ed.) (2025)
[85]
Cardiac Device-related Infective Endocarditis and Retrosternal Abscess Treated with Percutaneous Lead Extraction and Antimicrobials. — Sato T, Osawa T, Ochi A, Fumikura Y, Machino-Ohtsuka T, Yamasaki H et al. Internal medicine (Tokyo, Japan) (2025)
[86]
Interventional Treatment of Acute Right Ventricular Outflow Tract Infectious Endocarditis: A Bridge to Surgical or Percutaneous Pulmonary Valve Replacement. — Callegari A, Albertini M, Reverdito G, Bonnet D, Malekzadeh-Milani S Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2025)
[87]
Risk factors of infective endocarditis-associated acute kidney injury: benefits of low-dose amikacin and surgery. — Ai S, Liu X, Zhao N, Miao Q, Qin Y, Li X Annals of medicine (2025)
[88]
Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation. — Lee TTL, Ju C, Chan SCL, Chou OHI, Chan JSK, Lee S et al. Journal of the American Heart Association (2025)
[89]
Fatal Rhodococcus erythropolis endocarditis complicated by an abscess invading the atrioventricular node: a case report. — Yuan Y, Ma L, Liang Y, Zhao S, Shi Q, Yu Z et al. Forensic science, medicine, and pathology (2025)
[90]
Isolated pulmonary valve endocarditis in a 7-year-old Nigerian girl: a case report. — Alabi AO, Sayomi BA, Oladibu OT, Adetoye MM, Aderinto N, Akintunde AA Journal of medical case reports (2025)
[91]
Clinical and Imaging Characteristics of Infective Endocarditis-Associated Versus Atrial Fibrillation-Associated Stroke. — Kim T, Song K, Oh H, Song JY, Lee K, Sun BJ et al. Journal of the American Heart Association (2025)
[92]
A case of infective endocarditis with the manifestation of multi-organ embolisms: a case report. — Yu L, Lv T, Yang Y Cardiovascular journal of Africa (2025)
[93]
Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures: A Systematic Review and Meta-Analysis. — Sperotto F, France K, Gobbo M, Bindakhil M, Pimolbutr K, Holmes H et al. JAMA cardiology (2024)
[94]
The 2023 new European guidelines on infective endocarditis: main novelties and implications for clinical practice. — Imazio M Journal of cardiovascular medicine (Hagerstown, Md.) (2024)
[95]
Evaluation of the specificity of the 2023 European Society of Cardiology classification for infective endocarditis. — Moisset H, Rio J, Suc G, Benhard J, Arnoult F, Deconinck L et al. Infectious diseases (London, England) (2024)
[96]
Make Modern Microbiology Matter More in the 2023 European Society of Cardiology Guidelines for the Management of Infective Endocarditis. — Oldberg K, Rasmussen M Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
[97]
Evaluation of the 2023 Duke-ISCVID and 2023 Duke-ESC Clinical Criteria for the Diagnosis of Infective Endocarditis in a Multicenter Cohort of Patients With Staphylococcus aureus Bacteremia. — Papadimitriou-Olivgeris M, Monney P, Frank M, Tzimas G, Tozzi P, Kirsch M et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
[98]
Lower Specificity of the European Society of Cardiology 2023 Diagnostic Criteria for Infective Endocarditis When Spondylodiscitis Is Regarded as a Vascular Phenomenon. — Sunnerhagen T, Rasmussen M Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
[99]
Compared Performance of the 2023 Duke-International Society for Cardiovascular Infectious Diseases, 2000 Modified Duke, and 2015 European Society of Cardiology Criteria for the Diagnosis of Infective Endocarditis in a French Multicenter Prospective Cohort. — Goehringer F, Lalloué B, Selton-Suty C, Alla F, Botelho-Nevers E, Chirouze C et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
[100]
Infective endocarditis and septic arthritis caused by Corynebacteriumstriatum. — Umemoto D, Hara S, Nishioka H Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (2024)

Share:Twitter Reddit LinkedIn